Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$589.6M
+0.7% from 2023
Prescriptions
94K
$6,251.85 per claim
Patients
13K
6,166 prescribers
Total spending, 2024
$589.8M
$46,879.82 per patient
Medicare prescription drug plans paid $589.6M for Xeljanz Xr in 2024, for 94,306 prescriptions and refills to 12,575 patients (up 0.7% from 2023). The average cost per claim was $6,251.85.
New York had the highest Medicare cost for Xeljanz Xr in 2024: $59.6M for 8,946 claims, followed by California ($49.8M).
Michael Babilonia Roman, internal medicine in Mayaguez, PR, had the highest Medicare cost for Xeljanz Xr in 2024: 260 claims costing $1.5M.
Xeljanz Xr is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Michael Babilonia Roman Mayaguez, PR | Internal Medicine | 260 | 26 | $1.5M |
| Srikanth Naramala Visalia, CA | Rheumatology | 227 | 36 | $1.4M |
| Lalitha Ananth |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 6,260 | 101,580 | 13,969 | $590.9M |
| 2023 | 6,065 | 94,040 | 12,491 | $585.6M |
| 2024 | 6,166 | 94,306 | 12,575 | $589.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Rheumatology |
| 208 |
| 33 |
| $1.2M |
| Faisal Chaudhary Saratoga Springs, NY | Internal Medicine | 194 | 23 | $1.2M |
| Lauren Stock Springfield, MO | Physician Assistant | 150 | 20 | $1.0M |
| David M Pugliese Wilkes Barre, PA | Rheumatology | 169 | 27 | $992K |
| Gretchen J Crawford Tucson, AZ | Nurse Practitioner | 156 | 32 | $970K |
| Rupal Chavda Pueblo, CO | Rheumatology | 159 | 20 | $952K |
| Martin Morell New Hartford, NY | Rheumatology | 125 | 19 | $952K |
| Aaron C Garza Romero San Antonio, TX | Rheumatology | 148 | 15 | $943K |
| Christy C Park Knoxville, TN | Rheumatology | 165 | 19 | $939K |
| Gary E Solomon New York, NY | Internal Medicine | 149 | 16 | $929K |
| Shabana C Karim Greenville, MS | Rheumatology | 151 | 17 | $908K |
| Naiara Alvarez Harlingen, TX | Rheumatology | 153 | 22 | $877K |
| Zaida Z Fuxench Lopez Bayamon, PR | Internal Medicine | 144 | 18 | $856K |
| Andrew J Porges New Hyde Park, NY | Rheumatology | 92 | 15 | $791K |
| Ulker Tok Tucson, AZ | Rheumatology | 127 | 38 | $780K |
| Ana M Ballester-Fiallo San Antonio, TX | Rheumatology | 121 | 14 | $774K |
| Ray H McLaughlin Jr. Tuscaloosa, AL | Rheumatology | 135 | 14 | $773K |
| Mark J Bele Middletown, NY | Rheumatology | 126 | 14 | $772K |
| Dianne M Cooper Wichita Falls, TX | Rheumatology | 115 | 16 | $767K |
| Joseph C Shanahan Durham, NC | Rheumatology | 132 | 12 | $767K |
| Michael Hait Dartmouth, MA | Rheumatology | 124 | 13 | $752K |
| Maryanne Wysell Poughkeepsie, NY | Rheumatology | 101 | 14 | $749K |
| John K Botson Anchorage, AK | Rheumatology | 79 | 11 | $749K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 94,342 | $589.8M |